Tigermed Selected as One of the Top International Brands
HANGZHOU, China — Tigermed has been acknowledged as one of the Top 30 companies in the prestigious "2025 Forbes China Go-International Flagship Brands" list, as announced by Forbes China. This recognition highlights the commitment and growth of Chinese businesses venturing onto the global stage.
The Go-International Ranking Initiative
Forbes China initiated the Go-International ranking framework in recent years to monitor and celebrate companies that are strategically expanding beyond national borders. The 2025 ranking introduces several categories, including Flagship Brands, Leading Brands, Investment Value Brands, and Leading Figures. The flagship category specifically recognizes established, mature companies that have successfully built significant international footprints.
Understanding Flagship Brands
Flagship Brands are characterized by their expansive overseas operations, heavy investments in production, research and development, and a shift from merely exporting products to managing large-scale global operations. This evolution marks a critical phase in the branding journey of these companies.
Tigermed's Global Impact
Tigermed's inclusion in this esteemed list is a testament to the company's escalating influence and contribution within the biopharmaceutical sector on a global scale. As a leader in clinical development services, Tigermed operates over 180 offices worldwide, employing more than 10,000 staff across North America, Europe, Asia-Pacific, Africa, and Latin America. The company is steadfast in its goal to foster an end-to-end integrated platform that opens numerous possibilities within the healthcare industry.
Future Aspirations of Tigermed
Tigermed has outlined plans to persist in expanding its global presence while simultaneously enhancing local operations and advancing digital transformation. These steps are aimed at meeting the rising international demand for quality healthcare solutions. Furthermore, the company is dedicated to strengthening industry collaborations to push forward China's pharmaceutical innovations, aiming to provide superior research-driven healthcare solutions to patients worldwide.
Commitment to Quality and Innovation
The company’s commitment to excellence is reflected in its collaborative efforts with over 3,600 customers, emphasizing a seamless and efficient development journey from preclinical stages through to commercialization. Their broad range of services is designed to address unmet patient needs while striving to save lives.
About Tigermed
Tigermed (Stock code: 300347.SZ/3347.HK) is a prominent global provider of integrated research and development solutions within the biopharmaceutical and medical device sectors. With a vast portfolio of services, Tigermed is committed to delivering high-quality solutions as it works with clients worldwide. Visit their website for further information and insight into their innovative approaches.
Frequently Asked Questions
What does the recognition from Forbes China signify for Tigermed?
This recognition reflects Tigermed's strong global influence and leadership in the biopharmaceutical sector, highlighting their commitment to international expansion.
What are the criteria for the Go-International ranking?
The ranking assesses companies based on their global operational footprint, investment in overseas activities, and overall performance as matured brands.
How does Tigermed contribute to global healthcare?
Tigermed enhances healthcare solutions through its extensive research, development services, and commitment to meeting patient needs across various regions.
What future plans does Tigermed have for international growth?
Tigermed plans to expand its global presence further, adopt digital transformations, and deepen industry partnerships to enhance its international offerings.
Where can one learn more about Tigermed?
For additional insights and information, one can explore their official website, which outlines their services and commitment to innovation in healthcare.
